The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(1-amino-3-(1,4-dioxo-1,2,3,4-tetrahydrophthalazin-6-yl)-1,3-dioxopropan-2-yl)-3-methylbenzamide ID: ALA5195249
PubChem CID: 168285077
Max Phase: Preclinical
Molecular Formula: C19H16N4O5
Molecular Weight: 380.36
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(C(=O)N[C@H](C(N)=O)C(=O)c2ccc3c(=O)[nH][nH]c(=O)c3c2)c1
Standard InChI: InChI=1S/C19H16N4O5/c1-9-3-2-4-11(7-9)17(26)21-14(16(20)25)15(24)10-5-6-12-13(8-10)19(28)23-22-18(12)27/h2-8,14H,1H3,(H2,20,25)(H,21,26)(H,22,27)(H,23,28)/t14-/m0/s1
Standard InChI Key: LHWBWMHNRNWQRA-AWEZNQCLSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
-3.2138 0.2061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9284 -0.2061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5019 -0.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5019 -1.0309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2120 -1.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9284 -1.0346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2120 -2.2677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7873 0.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7873 1.0320 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0726 -0.2057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3580 0.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3565 -0.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3580 1.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0726 1.4446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3565 1.4446 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0712 0.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3565 -1.0309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7889 -0.2075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5007 0.2089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4991 1.0300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0713 1.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7843 1.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2138 1.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2138 2.2677 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9284 1.0300 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9284 0.2048 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2153 -0.2034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2153 -1.0288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
2 6 1 0
5 7 1 0
3 8 1 0
8 9 2 0
8 10 1 0
10 11 1 0
11 12 1 6
11 13 1 0
13 14 2 0
13 15 1 0
12 16 1 0
12 17 2 0
16 18 1 0
19 18 2 0
20 19 1 0
21 16 2 0
22 21 1 0
22 20 2 0
20 23 1 0
23 24 2 0
23 25 1 0
25 26 1 0
19 27 1 0
27 26 1 0
27 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 380.36Molecular Weight (Monoisotopic): 380.1121AlogP: -0.01#Rotatable Bonds: 5Polar Surface Area: 154.98Molecular Species: NEUTRALHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.75CX Basic pKa: ┄CX LogP: 0.12CX LogD: -0.02Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.36Np Likeness Score: -0.77
References 1. Nizi MG, Maksimainen MM, Murthy S, Massari S, Alaviuhkola J, Lippok BE, Sowa ST, Galera-Prat A, Prunskaite-Hyyryläinen R, Lüscher B, Korn P, Lehtiö L, Tabarrini O.. (2022) Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15., 237 [PMID:35500474 ] [10.1016/j.ejmech.2022.114362 ]